Company Filing History:
Years Active: 2016
Title: The Innovative Contributions of Nicholas J. Wang in Cancer Research
Introduction
Nicholas J. Wang is an esteemed inventor located in Portland, OR, who has made significant contributions to the field of cancer research. He is recognized for his innovative work in developing molecular predictors that enhance the therapeutic response to specific anti-cancer agents. With a unique approach to utilizing breast cancer cell lines, his research stands at the intersection of genomics and clinical application.
Latest Patents
Wang holds a noteworthy patent titled "Molecular predictors of therapeutic response to specific anti-cancer agents." This patent outlines the use of a collection of 50 breast cancer cell lines to match responses to 77 conventional and experimental therapeutic agents with their corresponding transcriptional, proteomic, and genomic subtypes found in primary tumors. His research demonstrated that almost all compounds elicited strong differential responses among the cell lines, which aligned with specific transcriptional and proteomic subtypes as well as recurrent genomic copy number abnormalities. This groundbreaking work enables the integration of these associations into clinical trials, allowing for the simultaneous testing of subtype markers and clinical responses.
Career Highlights
Nicholas J. Wang is associated with the University of California, where he continues to push the boundaries of cancer research through innovative methodologies. His career is marked by a commitment to bridging the gap between laboratory findings and clinical applications, helping to improve patient outcomes in oncology.
Collaborations
Wang has collaborated with esteemed colleagues, including Paul T. Spellman and Joe W. Gray, who have played pivotal roles in advancing his research. These collaborations reflect the interdisciplinary nature of modern medical research, where combining expertise can lead to transformative discoveries.
Conclusion
Nicholas J. Wang's contributions to the field of cancer research through his patent and collaborative efforts underscore the importance of innovation in developing new therapeutic strategies. His work not only enhances our understanding of cancer biology but also paves the way for improved treatments, potentially changing the landscape of cancer therapies for patients worldwide.